Skip to main content
SpringerLink
Log in

Psychopharmaka in Schwangerschaft und Stillzeit

  • Chapter
  • First Online:
Kompendium der Psychiatrischen Pharmakotherapie

Zusammenfassung

Es wird eine praxisrelevante Übersicht zu den Risiken von Psychopharmaka in Schwangerschaft und Stillzeit gegeben. Sehr ausführlich wird das Risiko von Antidepressiva besprochen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Anderson KN, Ailes EC, Lind JN et al (2020) Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997–2011. Schizophr Res 215:81–88

    Article  Google Scholar 

  • Biffi A, Cantarutti A, Rea F et al (2020) Use of antidepressants during pregnancy and neonatal outcomes: an umbrella review of meta-analyses of observational studies. J Psychiatr Res 124:99–108

    Article  Google Scholar 

  • Cuomo A, Goracci A, Fagiolini A (2018) Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J Affect Disord 228:229–237

    Article  CAS  Google Scholar 

  • Damkier P, Videbech P (2018) The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs 32(4):351–366

    Article  CAS  Google Scholar 

  • Dathe K, Schaefer C (2019) The use of medication in pregnancy. Dtsch Arztebl Int 116:783–790

    PubMed  PubMed Central  Google Scholar 

  • Datta P, Baker T, Hale TW (2019) Balancing the use of medications while maintaining breastfeeding. Clin Perinatol 46(2):367–382

    Article  Google Scholar 

  • DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Hrsg) für die Leitliniengruppe Unipolare Depression (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Aufl. Version 2. http://www.depression.versorgungsleitlinien.de. Zugegriffen: 13. Mai 2018

  • Dragioti E, Solmi M, Favaro A et al (2019) Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiatry 76(12):1241–1255

    Article  Google Scholar 

  • Ellfolk M, Leinonen MK, Gissler M et al (2020) (2020) Second-generation antipsychotics and pregnancy complications. Eur J Clin Pharmacol 76((1):107–115

    Article  CAS  Google Scholar 

  • Fitton CA, Steiner MFC, Aucott L et al (2020) In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review. Acta Psychiatr Scand 141(1):21–33

    Article  CAS  Google Scholar 

  • Fornaro M, Maritan E, Ferranti R et al (2020) Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry 177(1):76–92

    Article  Google Scholar 

  • Hernandez-Diaz S, Huybrechts KF, Desai RJ et al (2018) Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study. Neurology 90(4):e342–e351

    Article  CAS  Google Scholar 

  • Huybrechts KF, Hernández-Díaz S, Patorno E et al (2016) Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry 73(9):938–946

    Article  Google Scholar 

  • Huybrechts KF, Bröms G, Christensen LB et al (2018) Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the International Pregnancy Safety Study Consortium. JAMA Psychiatry 75(2):167–175

    Article  Google Scholar 

  • Huybrechts KF, Bateman BT, Pawar A et al (2020) Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ 368:m237

    Article  Google Scholar 

  • Kaltenbach K, O’Grady KE, Heil SH (2018) Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. Drug Alcohol Depend 185:40–49

    Article  CAS  Google Scholar 

  • Lugo-Candelas C, Cha J, Hong S (2018) Associations between brain structure and connectivity in infants and exposure to selective serotonin reuptake inhibitors during pregnancy. JAMA Pediatr 172(6):525–533

    Article  Google Scholar 

  • Mesches GA, Wisner KL, Betcher HK (2020) A common clinical conundrum: antidepressant treatment of depression in pregnant women. Semin Perinatol 25:151229

    Article  Google Scholar 

  • Molenaar NM, Bais B, Lambregtse-van den Berg MP (2020) The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J Affect Disord 264:82–89

    Article  Google Scholar 

  • Nechanská B, Mravčík V, Skurtveit S (2018) Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Addiction 113(7):1286–1294

    Article  Google Scholar 

  • Onken M, Mick I, Schaefer C (2018) Paliperidone and pregnancy – an evaluation of the German Embryotox database. Arch Womens Ment Health 21(6):657–662

    Article  Google Scholar 

  • Ornoy A, Koren G (2019) SSRIs and SNRIs (SRI) in pregnancy: effects on the course of pregnancy and the offspring: how far are we from having all the answers? Int J Mol Sci 20(10):2370

    Article  Google Scholar 

  • Patorno E, Bateman BT, Huybrechts KF et al (2017a) Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology 88(21):2020–2025

    Article  CAS  Google Scholar 

  • Patorno E, Huybrechts KF, Bateman BT et al (2017b) Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 376(23):2245–2254

    Article  CAS  Google Scholar 

  • Paulzen M, Goecke TW, Stingl J et al (2017a) Pregnancy exposure to citalopram – therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. Prog Neuropsychopharmacol Biol Psychiatry 79(Pt B):213–219

    Article  CAS  Google Scholar 

  • Paulzen M, Goecke TW, Stickeler E et al (2017b) Sertraline in pregnancy – therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. J Affect Disord 212:1–6

    Article  CAS  Google Scholar 

  • Paulzen M, Goecke TW, Kuzin M et al (2017c) Pregnancy exposure to quetiapine – therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes. Schizophr Res 195:252–257

    Article  Google Scholar 

  • Paulzen M, Schneider H, Schoretsanitis G (2019a) Therapiesicherheit durch „Therapeutisches Drug Monitoring“ Pharmakotherapie bipolarer Störungen in Schwangerschaft und Stillzeit. NeuroTransmitter 7–8:40

    Article  Google Scholar 

  • Paulzen M, Stingl JC, Augustin M et al (2019b) Comprehensive measurements of intrauterine and postnatal exposure to lamotrigine. Clin Pharmacokinet 58(4):535–543

    Article  CAS  Google Scholar 

  • Paulzen M, Schoretsanitis G, Gründer G et al (2020) Pregnancy exposure to venlafaxine – therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes. J Affect Disord 266:578–584

    Article  CAS  Google Scholar 

  • Pinheiro EA, Wisner KL, Clark CT (2018) Quetiapine dose adjustments in pregnant and postpartum women with bipolar disorder. J Clin Psychopharmacol 38(1):89–91

    Article  Google Scholar 

  • Rose S, Dotters-Katz SK, Kuller JA (2020) Electroconvulsive therapy in pregnancy: safety, best practices, and barriers to care. Obstet Gynecol Surv 75(3):199–203

    Article  Google Scholar 

  • Schoretsanitis G, Augustin M, Saßmannshausen H et al (2019) Antidepressants in breast milk; comparative analysis of excretion ratios. Arch Womens Ment Health 22(3):383–390

    Article  Google Scholar 

  • Schoretsanitis G, Spigset O, Stingl JC et al (2020a) The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis. Expert Opin Drug Metab Toxicol 16(5):431–440

    Article  CAS  Google Scholar 

  • Schoretsanitis G, Westin AA, Deligiannidis KM et al (2020b) Excretion of antipsychotics into the amniotic fluid, umbilical cord blood, and breast milk: a systematic critical review and combined analysis. Ther Drug Monit 42(2):245–254

    Article  CAS  Google Scholar 

  • Sheehy O, Zhao JP, Bérard A (2019) Association between incident eExposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry 76(9):948–957

    Article  Google Scholar 

  • Sinha P, Goyal P, Andrade C (2017) A meta-review of the safety of electroconvulsive therapy in pregnancy. J Ect 33(2):81–88

    Article  Google Scholar 

  • Sujan AC, Rickert ME, Öberg AS et al (2017) Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA 317(15):1553–1562

    Article  Google Scholar 

  • Westin AA, Brekke M, Molden E et al (2017) Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway. BMJ Open 7(3):e15738

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mannheim, Deutschland

    PD Dr. med. Michael Paulzen

  2. Mainz, Deutschland

    Otto Benkert

Authors
  1. PD Dr. med. Michael Paulzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Otto Benkert .

Editor information

Editors and Affiliations

  1. ehemals Universitäts-Klinikum Mainz, Mainz, Germany

    Otto Benkert

  2. Klinik für Psychiatrie und Psychotherapie, ehemals Universitäts-Klinikum München Campus Innenstadt, München, Germany

    Hanns Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Paulzen, M., Benkert, O. (2021). Psychopharmaka in Schwangerschaft und Stillzeit. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61753-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-61753-3_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-61752-6

  • Online ISBN: 978-3-662-61753-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation